ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07642
0,32%
Bitcoin
62.811,40
6,24%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Viking Therapeutics Inc (VKTX)

  7. Viking Therapeutics Inc (VKTX) News

VKTX Viking Therapeutics Inc

76,99
1,23 (1,62%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:41:37
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
1,23 1,62% 76,99 22:41:37
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
74,40 72,88 77,68 76,97 75,76
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202422:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
24.4.202413:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
17.4.202422:05PRNUSViking Therapeutics to Report Financial Results for First..
26.3.202412:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
05.3.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:52EDGAR2Form 8-K - Current report
04.3.202422:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
01.3.202422:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29.2.202402:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
27.2.202423:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.2.202422:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
27.2.202413:04EDGAR2Form 8-K - Current report
27.2.202413:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
10.2.202402:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:01EDGAR2Form 144 - Report of proposed sale of securities
09.2.202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:56EDGAR2Form 144 - Report of proposed sale of securities
08.2.202422:33EDGAR2Form 144 - Report of proposed sale of securities
07.2.202423:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.2.202423:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.2.202422:09EDGAR2Form 8-K - Current report
07.2.202422:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
01.2.202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:32EDGAR2Form 144 - Report of proposed sale of securities
31.1.202422:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
31.1.202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202422:23EDGAR2Form 144 - Report of proposed sale of securities
20.1.202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:36EDGAR2Form 144 - Report of proposed sale of securities
05.1.202403:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
02.11.202321:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
25.10.202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25.10.202322:24EDGAR2Form 8-K - Current report
25.10.202322:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
23.10.202313:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
18.10.202322:05PRNUSViking Therapeutics to Report Financial Results for Third..
18.10.202315:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
18.10.202315:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
17.10.202322:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
10.10.202322:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..
07.9.202322:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
06.9.202313:03PRNUSViking Therapeutics Announces Initiation of Phase 2 VENTURE..
26.7.202323:26EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26.7.202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26.7.202322:23EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten